← The library

GLP-2 analog (Teduglutide)

GI/Bone/Other
Evidence grade
AFDA-approved Rx (labeled use)
Cardiovascular · 0–5 · separate axis
1
PurposeGI / Short bowel syndrome
MechanismGLP-2 analog increases intestinal absorption and mucosal growth
EffectsGLP-2 analog increases intestinal absorption and mucosal growth
DosingNo human dose established.
Bottom lineStrongest data when used for its labeled indication under clinician guidance.
Batches on filenone

No tested batches on file.

Read with10
Cautions & interactions

Risk of GI obstruction, biliary/pancreatic issues; clinician-only

No well-established interaction profile for non-approved peptides; avoid combining multiple research compounds; discuss meds with clinician.

CV 1 of 5 — No solid direct cardiovascular outcomes evidence; any benefit is indirect or unproven.